Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and… Grant US-11912711-B2 United States of America 27 Feb 2024
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and… Grant US-11884675-B2 United States of America 30 Jan 2024
COMPOSITIONS AND METHODS FOR TREATMENT OF NEUROLOGICAL DISORDERS Application WO-2023150552-A1 World Intellectual Property Organisation (WIPO) 10 Aug 2023
Heterocyclic compounds as triggering receptor expressed on myeloid cells2 agonists and… Grant US-11718617-B2 United States of America 08 Aug 2023